Correlation Between Anika Therapeutics and Artivion

Can any of the company-specific risk be diversified away by investing in both Anika Therapeutics and Artivion at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anika Therapeutics and Artivion into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Anika Therapeutics and Artivion, you can compare the effects of market volatilities on Anika Therapeutics and Artivion and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anika Therapeutics with a short position of Artivion. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anika Therapeutics and Artivion.

Diversification Opportunities for Anika Therapeutics and Artivion

-0.69

Correlation Coefficient

Anika Therapeutics  Artivion

Excellent diversification

The 3 months correlation between Anika and Artivion is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Anika Therapeutics and Artivion in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Artivion and Anika Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anika Therapeutics are associated (or correlated) with Artivion. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Artivion has no effect on the direction of Anika Therapeutics i.e., Anika Therapeutics and Artivion go up and down completely randomly.

Pair Corralation between Anika Therapeutics and Artivion

Given the investment horizon of 90 days Anika Therapeutics is expected to under-perform the Artivion. In addition to that, Anika Therapeutics is 2.45 times more volatile than Artivion. It trades about -0.11 of its total potential returns per unit of risk. Artivion is currently generating about 0.07 per unit of volatility. If you would invest  2,714  in Artivion on August 30, 2024 and sell it today you would earn a total of  191.00  from holding Artivion or generate 7.04% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Anika Therapeutics  vs.  Artivion

Anika Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Anika Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's forward indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Artivion

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Artivion are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, Artivion may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Pair Trading with Anika Therapeutics and Artivion

The main advantage of trading using opposite Anika Therapeutics and Artivion positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anika Therapeutics position performs unexpectedly, Artivion can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Artivion will offset losses from the drop in Artivion's long position.

The idea behind Anika Therapeutics and Artivion pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.